Clinical Trial Update: Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the targeted alpha therapy At-211 PSMA-5 for prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• At-211 PSMA-5 (Astatine-211 PSMA-5)

Snippet

Sponsor: Osaka University | Conditions: Prostate Cancer | Phase 1 | Status: RECRUITING